Phase i trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer
โ Scribed by Bruce D. Minsky; Alfred M. Cohen; Warren E. Enker; David P. Kelsen; Nancy Kemeny; Bonnie Riechman; Leonard Saltz; Elin R. Sigurdson; Joanne Frankel
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 878 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Twenty patients with primary or recurrent unresectable rectal cancer limited to the pelvis were entered on a Phase I trial of preoperative pelvic radiation therapy (RT) (5040 cGy) and two cycles of combined high-dose leucovorin (LV) and 5fluorouracil (S-FU), followed by surgery and ten cycles of pos
Background. The encouraging results seen in patients who received postoperative combined modality therapy in the adjuvant setting have prompted increased interest in preoperative combined modality therapy for patients with unresectable rectal cancer. The authors report the local control and survival